Medtronic reported 4.1% organic revenue growth and 6.2% adjusted EPS growth. See why we upgraded MDT stock to 'Buy' with a ...

The FDA recall affects more than 25,000 of the Fridley-run company’s devices and follows reports of 17 injuries.

Medtronic initiated the recall of certain Pipeline Vantage embolisation devices in January 2025 following reports of four ...

Of the 22 guru strategies we follow, MDT rates highest using our Multi-Factor Investor model based on the published strategy of Pim van Vliet. This multi-factor model seeks low volatility stocks ...

Of the 22 guru strategies we follow, MDT rates highest using our Multi-Factor Investor model based on the published strategy of Pim van Vliet. This multi-factor model seeks low volatility stocks ...

Let’s examine Medtronic’s valuation and outlook in more detail to determine if there’s still a bargain opportunity. According to our valuation model, Medtronic seems to be fairly priced at ...

TVA has a distinct opportunity to become the testbed for cutting-edge energy solutions, and Tennessee cannot drive innovation ...

For its Pipeline Vantage 021 models, Medtronic is updating the instructions for use. And for the Pipeline Vantage 027 model, the company is asking doctors to return them, the agency said.

Four years into the mutually negotiated 10-year contract between Diabeter, a type 1 diabetes mellitus care-integrated ...

Explore MDT’s full potential at InvestingPro. Investing.com’s ProPicks, an AI-driven service trusted by over 130,000 paying members globally, provides easy-to-follow model portfolios designed ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...

Medtronic plc (NYSE:MDT ... while the diabetes segment represents a smaller portion. This diversified model enhances financial stability. Notably, the company experienced a rare decline in ...